Skip to main content
    C

    Cardio Diagnostics Holdings Inc (CDIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.71
    -0.08 (-4.47%)

    Market Cap: $5.30M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Cardio Diagnostics Holdings Inc (CDIO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Cardio Diagnostics Holdings (CDIO) has a market cap of $5.30M and an enterprise value of $1.35M. It kept -42721.93% of revenue as net income over the last 12 months. Its share count is up 68.35% from a year earlier.

    Total Valuation

    Enterprise value is 74.43% below the market cap, as cash exceeds debt.

    Market Cap$5.30M
    Enterprise Value$1.35M
    Latest price (Nov 17, 2026)$1.71

    Key Dates

    The next earnings report is expected on Mar 11, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 11, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 90.59% a year over 2 years.

    Shares Outstanding2.96M
    Shares Change (YoY)+68.35%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+90.59%

    Valuation Ratios

    Sales and book value multiples are 333.3x and 0.9x.

    P/S Ratio333.3x
    P/B Ratio0.9x
    P/TBV Ratio1.1x

    Price Statistics

    The stock is down 49.85% over 52 weeks and trades 7.07% below its 50-day average.

    Beta (1Y)2.46
    52-Week Change-49.85%
    1-Month Change+4.27%
    3-Month Change-14.07%
    6-Month Change+24.82%
    Total Return (1Y)-49.85%
    Total Return (3Y CAGR)-61.38%
    Return vs SPY (1Y)-48.92%
    Max Drawdown (1Y)-79.08%
    Max Drawdown (3Y)-98.86%
    Sharpe Ratio (1Y)-0.35
    Correlation with SPY (1Y)0.25
    50-Day Average$1.84
    200-Day Average$2.07
    52-Week Range$0.97 to $7.91
    RSI (14 Days)45.3
    Average Volume (20 Days)17.42K

    Price chart

    Financial Position

    Current assets cover 17.44x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio17.44x
    Quick Ratio17.44x
    Debt / Equity0.00x
    Interest Coverage-565.89x

    Returns and Efficiency

    Return on equity is -113.45% and return on assets is -106.62% over the last 12 months.

    Return on Equity (ROE)-113.45%
    Return on Assets (ROA)-106.62%
    Return on Capital Employed (ROCE)-111.19%
    ROA (5Y Average)-96.25%
    ROIC (5Y Average)-63.54%
    Asset Turnover0.00x
    Receivables Turnover4.07x

    Scores

    CDIO has an Altman Z-Score of -2.30, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-2.30
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $15.19K over the last 12 months is down 3.78% from the 12 months before.

    Revenue$15.19K
    Revenue Growth (YoY)-3.78%
    Gross Profit$15.19K
    Operating Income-$6.48M
    Pretax Income-$6.49M
    Net Income-$6.49M
    EBITDA-$6.11M
    EBIT-$6.49M
    Reported EPS (TTM)-$2.53

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 94.08% of the $6.08M in total assets.

    Cash and Equivalents$3.94M
    Total Debt$0
    Net Cash$3.94M
    Net Cash Per Share$1.33
    Working Capital$4.10M
    Shareholder Equity$5.72M
    Book Value Per Share$1.93
    Tangible Book Value$4.69M
    Tangible Book Per Share$1.59
    Total Assets$6.08M
    Total Liabilities$366.00K

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$5.78M
    FCF Per Share-$1.96
    Depreciation and Amortization$380.69K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -42649.75%.

    Gross Margin100.00%
    Operating Margin-42649.75%
    Pretax Margin-42721.93%
    Net Margin-42721.93%
    EBITDA Margin-40214.89%
    EBIT Margin-42721.93%

    Growth

    Revenue grew 149.89% a year over 3 years.

    Revenue Growth (3Y CAGR)+149.89%
    Book Value Per Share Growth (2Y CAGR)+414.94%
    Tangible Book Per Share Growth (2Y CAGR)+432.34%

    Revenue and profit by year

    Dividends and Yields

    CDIO does not pay a dividend.

    Buyback Yield-78.18%
    Shareholder Yield-78.18%

    Stock Splits

    The last split was a 1-for-30 reverse split on May 13, 2025.

    Last Split DateMay 13, 2025
    Split TypeReverse split
    Split Ratio1:30

    Peer Position

    Against 5 similar companies, CDIO has the highest P/S.

    P/S Ratio333.3x vs 13.8x median
    Revenue Growth (Trailing 4 Quarters, YoY)-3.78% vs -98.74% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CDIO

    What is CDIO's market cap?

    Cardio Diagnostics Holdings has a market cap of $5.30M. Its enterprise value, which adds debt and subtracts cash, is $1.35M.

    How many shares of CDIO are outstanding?

    Cardio Diagnostics Holdings has 2.96M shares outstanding. The count is up 68.35% from a year earlier.

    Does CDIO pay a dividend?

    No. Cardio Diagnostics Holdings does not pay a dividend.

    How much debt does CDIO have?

    Cardio Diagnostics Holdings has $0 of total debt and $3.94M of cash and equivalents, a net cash position of $3.94M.